Research Article

Efficacy and Safety of Clearing Heat and Detoxifying Injection in the Treatment of Influenza: A Randomized, Double-Blinded, Placebo-Controlled Trial

Table 1

Demographic characteristics of the participants and clinical characteristics of influenza-infected participants.

CharacteristicStudy groups
CHDI, 30 mL
()
Oseltamivir, 75 mL
()

Age, mean (SD), y37.9 (13.9)38.4 (14.5)
Men, number (%)12 (50.00)7 (31.81)
Drug used before enrollment, number (%)0 (0)0 (0)
Merge other disease, number (%)0 (0)0 (0)
Infected, number (%)18 (75)16 (72)
 Influenza A1413
 Influenza B43

Individuals infected with influenza
()()

Duration of illness before study,
mean (SD), h
15.50 (14.00)19.00 (13.00)
Axillary temperature, mean (SD), °C38.66 (0.22)38.78 (0.30)
Total symptoms severity score at enrollment, mean (SD)20.29 (4.71)20.35 (4.83)

CHDI: clearing heat and detoxifying injection.
Influenza A virus infections were predominantly SWL; 2 infections in oseltamivir group were due to H3N2 virus.